BRUNO PALMA GRANWEHR to Female
This is a "connection" page, showing publications BRUNO PALMA GRANWEHR has written about Female.
Connection Strength
0.172
-
In complicated UTIs, cefepime-taniborbactam increased treatment success vs. meropenem at 19 to 23 d. Ann Intern Med. 2024 Jun; 177(6):JC67.
Score: 0.026
-
In women with uncomplicated UTIs, gepotidacin was noninferior to nitrofurantoin for therapeutic response at 10 to 13 d. Ann Intern Med. 2024 06; 177(6):JC67.
Score: 0.026
-
Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study. Am J Gastroenterol. 2019 02; 114(2):250-257.
Score: 0.018
-
ACP Journal Club: quadrivalent HPV vaccination was not linked to multiple sclerosis or other demyelinating diseases. Ann Intern Med. 2015 Apr 21; 162(8):JC13.
Score: 0.014
-
ACP Journal Club. Review: Influenza vaccination reduces cardiovascular events in adults. Ann Intern Med. 2014 Feb 18; 160(4):JC2.
Score: 0.013
-
Implementation of Universal Hepatitis C Virus Screening in a Tertiary Cancer Center. J Natl Compr Canc Netw. 2024 05 10; 22(2 D).
Score: 0.007
-
Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors. Am J Gastroenterol. 2023 09 01; 118(9):1609-1617.
Score: 0.006
-
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period. Elife. 2023 02 07; 12.
Score: 0.006
-
High sustained virologic response rate after 8 weeks of direct-acting antivirals in cancer patients with chronic hepatitis C virus. Eur J Gastroenterol Hepatol. 2022 10 01; 34(10):1098-1101.
Score: 0.006
-
Improving the Prevalence of HIV Testing Among Patients in a Gynecologic Oncology Department: Results of a Quality Improvement Project. JCO Oncol Pract. 2020 01; 16(1):e109-e116.
Score: 0.005
-
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.004
-
A Novel Nonantibiotic Nitroglycerin-Based Catheter Lock Solution for Prevention of Intraluminal Central Venous Catheter Infections in Cancer Patients. Antimicrob Agents Chemother. 2017 07; 61(7).
Score: 0.004
-
False-positive HIV nucleic acid amplification testing during CAR T-cell therapy. Diagn Microbiol Infect Dis. 2017 Aug; 88(4):305-307.
Score: 0.004
-
Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer. 2016 12 01; 139(11):2519-28.
Score: 0.004
-
Development of non-Hodgkin lymphoma as a second primary cancer in hepatitis C virus-infected patients with a different primary malignancy. Leuk Lymphoma. 2017 02; 58(2):485-488.
Score: 0.004
-
Case-Control Study of Telavancin as an Alternative Treatment for Gram-Positive Bloodstream Infections in Patients with Cancer. Antimicrob Agents Chemother. 2016 01; 60(1):239-44.
Score: 0.004
-
HIV Testing in Patients With Cancer at the Initiation of Therapy at a Large US Comprehensive Cancer Center. J Oncol Pract. 2015 Sep; 11(5):384-90.
Score: 0.004
-
Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis. PLoS One. 2015; 10(6):e0129022.
Score: 0.004
-
Efficacy and safety of antiretrovirals in HIV-infected patients with cancer. Clin Microbiol Infect. 2014 Oct; 20(10):O672-9.
Score: 0.003
-
Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J. 2012 Apr; 31(4):373-8.
Score: 0.003
-
A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012 Sep 15; 118(18):4627-33.
Score: 0.003
-
Predictors of catheter-related gram-negative bacilli bacteraemia among cancer patients. Clin Microbiol Infect. 2011 Nov; 17(11):1711-6.
Score: 0.003
-
Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms. Cancer. 2010 Feb 15; 116(4):967-73.
Score: 0.002
-
Use of transgenic and gene-targeted mice to model the genetic basis of hypertensive disorders. Proc Assoc Am Physicians. 1997 Nov; 109(6):533-46.
Score: 0.001